ABBV

AbbVie

$224.69

-2.23 (-0.98%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 27.02.2026
$248.29
(+10.5%)
Strong Buy: 6
Buy: 13
Hold: 9
Sell: 0
Strong Sell: 1
Description:
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Exchange:
NYSE
Country:
USA
Sector:
HEALTHCARE
Industry:
DRUG MANUFACTURERS - GENERAL
Address:
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, UNITED STATES, 60064-6400
Fiscal year end:
December
Market capitalization:
$401 Billion
EBITDA:
$29.3 Billion
PERatio:
96.15
EPS:
2.36
Dividend per share:
$6.65
Dividend yield:
2.91%
Beta:
0.334

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 13 years:
+977%
How much will you get:
$10,775
Prices dates:
02-01-2013: $20.70 and 30-01-2026: $223.01